Literature DB >> 33571679

Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis.

Chaogang Yang1, Rongzhang Dou2, Chen Wei3, Keshu Liu2, Dongdong Shi1, Chunxiao Zhang1, Qing Liu2, Shuyi Wang4, Bin Xiong5.   

Abstract

Epithelial-mesenchymal transition (EMT) is reported to involve in the crosstalk between tumor cells and tumor-associated macrophages (TAMs). Exosomes are considered as important mediators of orchestrating intercellular communication. However, the underlying mechanisms by which EMT-colorectal cancer (CRC) cells promote the M2 polarization of TAMs remain less understood. In this study, we found that EMT-CRC cells promoted the M2-like polarization of macrophages by directly transferring exosomes to macrophages, leading to a significant increase of the microRNA-106b-5p (miR-106b) level in macrophages. Mechanically, an increased level of miR-106b activated the phosphatidylinositol 3-kinase (PI3K)γ/AKT/mammalian target of rapamycin (mTOR) signaling cascade by directly suppressing programmed cell death 4 (PDCD4) in a post-transcription level, contributing to the M2 polarization of macrophages. Activated M2 macrophages, in a positive-feedback manner, promote EMT-mediated migration, invasion, and metastasis of CRC cells. Clinically, miR-106b was significantly elevated in CRC tissues and negatively correlated with the levels of PDCD4 in CRC specimens, and high expression of exosomal miR-106b in plasma was significantly associated with the malignant progression of CRC. Taken together, our results indicate that exosomal miR-106b derived from EMT-CRC cells has an important role in intercellular communication for inducing M2 macrophage polarization, illuminating a novel mechanism underlying CRC progression and offering potential targets for prevention of CRC metastasis.
Copyright © 2021 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EMT; PDCD4; colorectal cancer; exosome; macrophages; miR-106b

Mesh:

Substances:

Year:  2021        PMID: 33571679      PMCID: PMC8178444          DOI: 10.1016/j.ymthe.2021.02.006

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   12.910


  52 in total

1.  Dynamic regulation of mRNA decay during neural development.

Authors:  Dana A Burow; Maxine C Umeh-Garcia; Marie B True; Crystal D Bakhaj; David H Ardell; Michael D Cleary
Journal:  Neural Dev       Date:  2015-04-21       Impact factor: 3.842

Review 2.  Liquid biopsy: monitoring cancer-genetics in the blood.

Authors:  Emily Crowley; Federica Di Nicolantonio; Fotios Loupakis; Alberto Bardelli
Journal:  Nat Rev Clin Oncol       Date:  2013-07-09       Impact factor: 66.675

Review 3.  Tumor-associated macrophages and epithelial-mesenchymal transition in cancer: Nanotechnology comes into view.

Authors:  Roghayyeh Vakili-Ghartavol; Reza Mombeiny; Arash Salmaninejad; Seyed Mahdi Rezayat Sorkhabadi; Reza Faridi-Majidi; Mahmoud Reza Jaafari; Hamed Mirzaei
Journal:  J Cell Physiol       Date:  2018-08-05       Impact factor: 6.384

Review 4.  Emerging Biological Principles of Metastasis.

Authors:  Arthur W Lambert; Diwakar R Pattabiraman; Robert A Weinberg
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

Review 5.  Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis.

Authors:  Annette Becker; Basant Kumar Thakur; Joshua Mitchell Weiss; Han Sang Kim; Hector Peinado; David Lyden
Journal:  Cancer Cell       Date:  2016-12-12       Impact factor: 31.743

6.  Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways.

Authors:  Mingyu Qian; Shaobo Wang; Xiaofan Guo; Jian Wang; Zongpu Zhang; Wei Qiu; Xiao Gao; Zihang Chen; Jianye Xu; Rongrong Zhao; Hao Xue; Gang Li
Journal:  Oncogene       Date:  2019-09-04       Impact factor: 9.867

7.  Hypoxic Lung-Cancer-Derived Extracellular Vesicle MicroRNA-103a Increases the Oncogenic Effects of Macrophages by Targeting PTEN.

Authors:  Ya-Ling Hsu; Jen-Yu Hung; Wei-An Chang; Shu-Fang Jian; Yi-Shiuan Lin; Yi-Chung Pan; Cheng-Ying Wu; Po-Lin Kuo
Journal:  Mol Ther       Date:  2017-11-29       Impact factor: 11.454

Review 8.  Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.

Authors:  Ladan Mashouri; Hassan Yousefi; Amir Reza Aref; Ali Mohammad Ahadi; Fatemeh Molaei; Suresh K Alahari
Journal:  Mol Cancer       Date:  2019-04-02       Impact factor: 27.401

Review 9.  Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions.

Authors:  Sachiko Matsuhashi; M Manirujjaman; Hiroshi Hamajima; Iwata Ozaki
Journal:  Int J Mol Sci       Date:  2019-05-09       Impact factor: 5.923

10.  MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.

Authors:  Nana Li; Yuan Miao; Yujia Shan; Bing Liu; Yang Li; Lifen Zhao; Li Jia
Journal:  Cell Death Dis       Date:  2017-05-18       Impact factor: 8.469

View more
  15 in total

Review 1.  The pleiotropic mode and molecular mechanism of macrophages in promoting tumor progression and metastasis.

Authors:  Xingxing Zhang; Wenxiu Bai; Lisha Hu; Hualan Ha; Yuelin Du; Wei Xiong; Hongbo Wang; Panfeng Shang
Journal:  Clin Transl Oncol       Date:  2022-09-07       Impact factor: 3.340

Review 2.  Phosphoinositide 3-kinase/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization.

Authors:  Depeng Yang; Lijun Yang; Jialing Cai; Huaxin Li; Zheng Xing; Ying Hou
Journal:  Mol Cell Biochem       Date:  2022-05-19       Impact factor: 3.842

3.  MicroRNA-182-5p Attenuates Asthmatic Airway Inflammation by Targeting NOX4.

Authors:  Zhiguang Wang; Yilan Song; Jingzhi Jiang; Yihua Piao; Li Li; Qiaoyun Bai; Chang Xu; Hanye Liu; Liangchang Li; Hongmei Piao; Guanghai Yan
Journal:  Front Immunol       Date:  2022-05-31       Impact factor: 8.786

Review 4.  Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment.

Authors:  Zijie Xu; Yi Chen; Ling Ma; Yizhang Chen; Jingya Liu; Yuchen Guo; Ting Yu; Lianghui Zhang; Lingjun Zhu; Yongqian Shu
Journal:  Mol Ther       Date:  2022-04-09       Impact factor: 12.910

Review 5.  Tissue-derived extracellular vesicles in cancers and non-cancer diseases: Present and future.

Authors:  Su-Ran Li; Qi-Wen Man; Xin Gao; Hao Lin; Jing Wang; Fu-Chuan Su; Han-Qi Wang; Lin-Lin Bu; Bing Liu; Gang Chen
Journal:  J Extracell Vesicles       Date:  2021-12

6.  Identification and Mechanism of the PD-1/PD-L1 Genomic Signature SORL1 as Protective Factor in Bladder Cancer.

Authors:  Yajing Xu; Didi Chen; Lanxiao Shen; Xiaowei Huang; Yi Chen; Huafang Su
Journal:  Front Genet       Date:  2021-12-16       Impact factor: 4.599

7.  Down-regulated C4orf19 confers poor prognosis in colon adenocarcinoma identified by gene co-expression network.

Authors:  Wanpeng Wang; Xiaolu Lin; Ran Yu; Suqin Zhou; Yanyan Liu; Haifeng Jia; Feng Han; Yanzhi Bu; Juan Pu
Journal:  J Cancer       Date:  2022-01-09       Impact factor: 4.207

Review 8.  Functional and Therapeutic Significance of Tumor-Associated Macrophages in Colorectal Cancer.

Authors:  Yitong Li; Zhenmei Chen; Jiahao Han; Xiaochen Ma; Xin Zheng; Jinhong Chen
Journal:  Front Oncol       Date:  2022-02-02       Impact factor: 6.244

Review 9.  Macrophages, as a Promising Strategy to Targeted Treatment for Colorectal Cancer Metastasis in Tumor Immune Microenvironment.

Authors:  Yingru Zhang; Yiyang Zhao; Qi Li; Yan Wang
Journal:  Front Immunol       Date:  2021-07-13       Impact factor: 7.561

Review 10.  Myeloid Responses to Extracellular Vesicles in Health and Disease.

Authors:  Priya Makhijani; Tracy L McGaha
Journal:  Front Immunol       Date:  2022-03-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.